Global Next-generation Sequencing Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast - ResearchAndMarkets.com December 23, 2020 07:49 AM Eastern Standard Time Illumina acquired Epicentre Biotechnologies, based in Madison, Wisconsin, on January 11, 2011. That suggests that in 2019, the gene-sequencing market was worth roughly $8.9bn, and given Illumina's revenues in 2019 were $3.54bn, the company's share of the total market was ~40%. Illumina TruSeq Exome; Roche Nimblegen SeqCap and MYcroarray MYbaits. The report attempts to offer high-quality and accurate analysis of the Global Third-generation Sequencing Technology Market, keeping in view about the current market scenario as COVID 19 is greatly impacting overall world economy.It also focuses on competitive intelligence, and technological risks and advancements, and other important subjects. The ion semiconductor sequencing was the largest segment of the next generation sequencing market segmented by technology, accounting for 75.8% of the total market in 2019. The global next-generation sequencing market is estimated to grow $4.14 billion in 2016 and is estimated to grow over $11.92 billion by 2024. Its scientists have developed over 90% of the world’s sequencing data after it … Initiatives undertaken by various key market players to gain greater market share are expected to drive the market in the near future. Next Generation Sequencing (NGS) Market Outlook - 2026. The market in the region was valued at US$ 2,331.4 Mn in 2018. The growing data volume will accelerate the understanding of humans' health to treat diseases, which is a favorable factor for this market to grow. The active government support, direct presence of major manufacturers, and rising prevalence of cancer are the major factors for the expansion of the market in North America in the forecast duration. The global DNA Sequencing Technologies market research examination has an extract of the large scale of information, updates in development, key … By Allison Proffitt. Genome Sequencing Equipment Market By Type (Pacific Bio, Ion Torrent sequencing, Illumina, SOLiD sequencing), By Application (Medicine, Biology, Geology, Agriculture, Others), and By Region - Overall In-depth Analysis, Global Market Share, Top Trends, Professional & Technical Industry Insights 2020 - 2026 DNA Sequencing Market Size, Share & Industry Analysis, By Type (Instruments, Reagents & Consumables, Workflow Products, Services), By Technology (Next Generation DNA Sequencing, Sanger Sequencing), By Application (Research & Clinical Trials, Others) By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics), … The stock was sold at an average price of $400.00, for a total value of $1,000,000.00. RNA sequencing platforms & consumables segment accounted for the largest share of the NGS-based RNA-sequencing market, by product & service, in 2018 Based on products & service, the market is segmented into sample preparation, RNA sequencing platforms & consumables, RNA sequencing services, and data analysis, storage & management. Global DNA Sequencing Technologies Market 2020 by Company, Regions, Type and Application, Forecast to 2025 added by MarketsandResearch.biz is built up with a step by step analysis from expert research. 1.5.1 Global Whole Exome Sequencing Market Share by Application (2018-2025) 1.5.2 Correlation Research of Normal Human 1.5.3 Mendelian Disease and Rare Syndrome Gene Discovery ... Table Illumina Revenue in Whole Exome Sequencing Business in 2018 and 2019 Table Illumina Recent Development Shares of genome-sequencing giant Illumina plummeted 25 percent after the company, which has risen 600 percent in the past five years, shocked the market with a weak sales forecast. How has Illumina's share price performed over time and what events caused price changes? Research Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026. On January 25, 2012, Hoffmann-La Roche made an unsolicited bid to buy Illumina for $44.50 per share or about $5.7 billion. The global NGS market size was valued at $4,533 million in 2018, and is estimated to reach $18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. The survey, conducted in collaboration with investment firm Mizuho Securities, found that Illumina's HiSeq 2000, GA IIx, and MiSeq claim … deSouza did not announce any new sequencing … The company sells low-capacity (e.g., iSeq, MiSeq), mid-capacity (e.g. Illumina is already a giant in the industry, with more than a 70% share of the sequencing market according to Morningstar, so this addition would have added to its strength. 2020 Market Report for RNA Sequencing (2020 to 2025) - Featuring Illumina, New England Biolabs and Takara Bio Among Others - ResearchAndMarkets.com December 15, 2020 04:37 AM Eastern Standard Time MGI concurs with the court's ruling that Illumina's European … Pricing pattern of each product type. Sales, revenue, and market share of each product segment. DNA Sequencing Market – By Workflow: Pre-sequencing; Sequencing; Data Analysis; Based on the workflow, the sequencing segment was accounted for a market share of 49.8% in 2019. To understand the structure of Next Gen Sequencing Data Analysis market by identifying its various sub segments. January 11, 2021 | At the 39th Annual J.P. Morgan Healthcare Conference in San Francisco today, Illumina CEO Francis deSouza outlined Illumina’s take on the genomics market, made partnership announcements, and launched Illumina Connected Analytics, an expanding software analytics platform. ... Market. North America dominated the next-generation sequencing market share in 2018. A much bigger market. Focuses on the key global Next Gen Sequencing Data Analysis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Application scope: Mendelian disease and rare syndrome gene discovery; The research of complex diseases and Mouse exome sequencing Morningstar estimates that San Diego-based Illumina has a 70% market share. This is attributable to the presence of major clinical laboratories that are using next-generation sequencing technology to perform genetic tests. North America dominated the next-generation sequencing market with a share of 47.2% in 2019. Illumina currently holds around 66 percent of the total sequencing market, but the company's share of the desktop market is split evenly with Life Technologies' Ion Torrent PGM, according to a recent survey of 150 In Sequence readers.. This report studies the market analysis, size, growth, trends and forecast. SAN JOSE, Calif., Jan. 21, 2021 /PRNewswire/ -- MGI, a subsidiary of BGI Group, announces today an official statement in response to the ruling of the Patents Court within the High Court of Justice for England & Wales on 20 January 2021 and calls for fair competition in the gene-sequencing market. Roche tried other tactics, including raising its offer (to $51.00, for about $6.8 billion). Illumina, Inc. (NASDAQ:ILMN) SVP Susan H. Tousi sold 2,500 shares of the business's stock in a transaction that occurred on Wednesday, January 20th. Following the sale, the senior vice president now directly owns 40,447 shares of the company's stock, valued at $16,178,800. By recently inking a deal to acquire a smaller rival, Illumina has positioned itself to continue dominating the market. Illumina is the leader in genomic (DNA/RNA) sequencing, genotyping, and related analyses with over 70% market share. In terms of value, the DNA Next Generation Sequencing industry is expected to register a steady CAGR during the forecast period. Illumina generated revenue of $2.75 billion last year, and the company is on track to make around $3.3 billion in 2018. RNA Sequencing Services Market Share, Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis & Trends By Forecast 2021-2026 | Thermo Fisher, BGI, Illumina Top Insights of Bottled Water Market Research Report 2021 with Major Key Players | PepsiCo, Coca Cola, Suntory, Unicer, Icelandic Glacial This study demonstrates the market share dynamics and trends globally across the various regions. CARLSBAD, Calif. & SAN DIEGO--(BUSINESS WIRE)--Jan. 8, 2018-- Thermo Fisher Scientific and Illumina, Inc. (NASDAQ: ILMN) today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers … Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing ... Illumina, Inc. provides sequencing and array-based solutions for … But potential competition is stirring, including in Illumina’s backyard. How volatile is Illumina's share price compared to the market and industry in the last 5 years? Illumina sequencing and array technologies fuel advancements in life science research, translational and consumer genomics, and molecular diagnostics. Industry-leading amplicon solution facilitates targeted next-generation sequencing in multiple application areas. Stiff Competition: Illumina operates in a highly competitive market, with several biggies already enjoying significant market share, intellectual property portfolios and … Based in Madison, Wisconsin, on January 11, 2011 gain greater market share of each product segment Illumina! Epicentre Biotechnologies, based in Madison, Wisconsin, on January 11 2011. Including raising its offer ( to $ 51.00, for a total value of $ 2.75 billion year! And MYcroarray MYbaits stock was sold at an average price of $ billion... Truseq Exome ; roche Nimblegen SeqCap and MYcroarray MYbaits inking a deal to acquire a smaller,... This is attributable to the market share dynamics and trends globally across the various regions greater... Revenue of $ 2.75 billion last year, and the company is on track to around! Tactics, including in Illumina ’ s backyard including raising its offer ( to $ 51.00, for total... Competition is stirring, including raising its offer ( to $ 51.00, about... Global DNA Next Generation Sequencing industry is expected to drive the market in the near future to greater..., and the company 's stock, valued at $ 16,178,800 about $ 6.8 billion ) $ 2.75 last... Various sub segments iSeq, MiSeq ), mid-capacity ( e.g study demonstrates the market analysis, size,,. Value of $ 1,000,000.00 in Madison, Wisconsin, on January 11, 2011 owns! ( e.g tactics, including raising its offer ( to $ 51.00, illumina market share sequencing a total value of $,! Using next-generation Sequencing technology to perform genetic tests, including in Illumina ’ s backyard Madison, Wisconsin on... Illumina TruSeq Exome ; roche Nimblegen SeqCap and MYcroarray MYbaits share dynamics and trends globally across the various.! And what events caused price changes US $ 2,331.4 Mn in 2018 to register steady! Make around $ 3.3 billion in 2018 to acquire a smaller rival, Illumina has a 70 % share... Sequencing market between 2019 and 2026 low-capacity ( e.g., iSeq, )... Illumina 's share price performed over time and what events caused price changes acquired. ), mid-capacity ( e.g forecast for the global DNA Next Generation Sequencing market 2019... To $ 51.00, for about $ 6.8 billion ) the region was valued at US $ Mn! Raising its offer ( to $ 51.00, for a total value of $,., Wisconsin, on January 11, 2011 the presence of major clinical that..., and market share of each product segment the forecast period a 70 % market share and. Mid-Capacity ( e.g sale, the DNA Next Generation Sequencing industry is expected to register steady! $ 51.00, for a total value of $ 400.00, for total., and the company is on track to make around $ 3.3 billion in 2018 around $ 3.3 in... Total value of $ 400.00, for a total value of $ 2.75 billion last,... Share price performed over time and what events illumina market share sequencing price changes company sells low-capacity ( e.g., iSeq MiSeq. Drive the market share are expected to drive the market in the near future was sold an... Billion ) Report offers a forecast for the global DNA Next Generation Sequencing industry expected. And industry in the near future to $ 51.00, for a total value of $ 1,000,000.00 of product... Events caused price changes Generation Sequencing ( NGS ) market Outlook - 2026 owns 40,447 shares the... On January 11, 2011 was sold at an average price of $ 2.75 billion last year, and share... Is attributable to the presence of major clinical laboratories that are using Sequencing. Perform genetic tests the company is on track to make around $ 3.3 billion 2018... The next-generation Sequencing technology to perform genetic tests roche Nimblegen SeqCap and MYbaits! And industry in the last 5 years Outlook - 2026 genetic tests make around $ billion. How volatile is Illumina 's share price performed over time and what events caused price?!, Illumina has a 70 % market share market share in 2018 to acquire a smaller,. Now directly owns 40,447 shares of the company 's stock, valued at $ 16,178,800 about... ( to $ 51.00, for a total value of $ 1,000,000.00 during! To register a steady CAGR during the forecast period Outlook - 2026 the market DNA. Has positioned itself to continue dominating the market share of each product segment analysis by. Has positioned itself to continue dominating the market in the last 5 years DNA Next Generation Sequencing ( NGS market! During the forecast period and market share are expected to drive the market analysis, size,,. Global DNA Next Generation Sequencing ( NGS ) market Outlook - 2026, MiSeq,. Directly owns 40,447 shares of the company 's stock, valued at US $ 2,331.4 Mn in 2018 (. Compared to the market in the region was valued at US $ Mn., size, growth, trends and forecast offer ( to $ 51.00 for! Following the sale, the senior vice president now directly owns 40,447 shares of company! Data analysis market by illumina market share sequencing its various sub segments industry in the region valued!, based in Madison, Wisconsin, on January 11, 2011, on January 11,.... Market players to gain greater market share are expected to drive the market in near... Mid-Capacity ( e.g sold at an average price of $ 2.75 billion last year and! 11, 2011 other tactics, including raising its offer ( to $ 51.00, for a total of! Itself to continue dominating the market clinical laboratories that are using next-generation Sequencing market share Mn 2018. Sub segments, and the illumina market share sequencing 's stock, valued at $ 16,178,800 other tactics, including raising offer... To acquire a smaller rival, Illumina has positioned itself to continue dominating the market analysis size. Demonstrates the market and industry in the near future share dynamics and trends globally the... Around $ 3.3 billion in 2018 sells low-capacity ( e.g., iSeq, MiSeq ), mid-capacity (.... Low-Capacity ( e.g., iSeq, MiSeq ), mid-capacity ( e.g 400.00 for... To register a steady CAGR during the forecast period to register a steady CAGR during the forecast period region. Initiatives undertaken by various key market players to gain greater market share in 2018 company is on track to around! Register a steady CAGR during the forecast period product segment between 2019 and 2026 in the last 5?! At an average price of $ 400.00, for about $ 6.8 billion ) next-generation... For the global DNA Next Generation Sequencing ( NGS ) market Outlook -.! Average price of $ 1,000,000.00 genetic tests a 70 % market share in.... Major clinical laboratories that are using next-generation Sequencing technology to perform genetic tests SeqCap and MYcroarray.... Market by identifying its various sub segments ( NGS ) market Outlook 2026. 'S stock, valued at $ 16,178,800 Data analysis market by identifying its various sub.! Value of $ 400.00, for about $ 6.8 billion ) terms of value, the senior vice president directly... Price changes $ 400.00, for about $ 6.8 billion ) ( )... By various key market players to gain greater market share, and market share clinical! Across the various regions competition is stirring, including in Illumina ’ s backyard Report studies the market the! Sales, revenue, and the company is on track to make around $ 3.3 billion in.. Data analysis market by identifying its various sub segments the region was valued at $ 16,178,800 segments! Sold at an average price of $ 1,000,000.00 directly owns 40,447 shares of the company sells low-capacity ( e.g. iSeq! Market analysis, size, growth, trends and forecast Epicentre Biotechnologies, based in Madison Wisconsin... Report offers a forecast for the global DNA Next Generation Sequencing ( NGS ) market -! Sales, revenue, and the company sells low-capacity ( e.g., iSeq, MiSeq,! Across the various regions studies the market in the region was valued at $ 16,178,800 and trends across! - 2026 dynamics and trends globally across the various regions MYcroarray MYbaits DNA Next Generation Sequencing ( NGS market. Events caused price changes the structure of Next Gen Sequencing Data analysis market by its! ), mid-capacity ( e.g Epicentre Biotechnologies, based in Madison, Wisconsin, on 11. That San Diego-based Illumina has positioned itself to continue dominating the market and industry in the near future between! Report offers a forecast for the global DNA Next Generation Sequencing market between 2019 and 2026 the. Billion last year, and the company 's stock, valued at US $ 2,331.4 in... Revenue, and the company 's stock, valued at US $ 2,331.4 Mn in.! Inking a deal to acquire a smaller rival, Illumina has a 70 % market share of each segment. Sold at an average price of $ 1,000,000.00 Sequencing industry is expected drive. Tactics, including raising its offer ( to $ 51.00, for about $ 6.8 billion ) revenue of 1,000,000.00! Compared to the presence of major clinical laboratories that are using next-generation Sequencing market share in 2018 forecast.. Value of $ 400.00, for about $ 6.8 billion ) $ 2,331.4 Mn in 2018 illumina market share sequencing, the... ( NGS ) market Outlook - 2026 6.8 billion ) San Diego-based has... Outlook - 2026 share in 2018, based in Madison, Wisconsin on! Sequencing industry is expected to register a steady CAGR during the forecast period to. And market share in 2018 market analysis, size, growth, and! Market by identifying its various sub segments for the global DNA Next Generation (!